Bone Biologics Correlations
| BBLGW Stock | USD 15.00 0.00 0.00% |
The current 90-days correlation between Bone Biologics Corp and Bone Biologics Corp is 0.18 (i.e., Average diversification). The correlation of Bone Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Bone Biologics Correlation With Market
Good diversification
The correlation between Bone Biologics Corp and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and DJI in the same portfolio, assuming nothing else is changed.
Moving against Bone Stock
| 0.33 | VSEE | VSee Health, | PairCorr |
| 0.37 | VVOS | Vivos Therapeutics | PairCorr |
| 0.33 | ELAB | Elevai Labs, Common | PairCorr |
| 0.38 | MGRM | Monogram Orthopaedics Trending | PairCorr |
| 0.31 | NDRA | ENDRA Life Sciences | PairCorr |
Related Correlations Analysis
| -0.18 | -0.77 | 0.0 | -0.02 | BBLG | ||
| -0.18 | 0.22 | 0.0 | 0.08 | BFRIW | ||
| -0.77 | 0.22 | 0.0 | -0.19 | IINNW | ||
| 0.0 | 0.0 | 0.0 | 0.0 | PETVW | ||
| -0.02 | 0.08 | -0.19 | 0.0 | KTTAW | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bone Stock performing well and Bone Biologics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bone Biologics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BBLG | 4.91 | (0.43) | 0.00 | (0.55) | 0.00 | 10.10 | 47.51 | |||
| BFRIW | 19.06 | 3.83 | 0.18 | 6.39 | 15.37 | 52.17 | 140.04 | |||
| IINNW | 10.99 | 2.78 | 0.17 | (18.75) | 9.15 | 26.32 | 170.25 | |||
| PETVW | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| KTTAW | 16.45 | 2.14 | 0.08 | (0.41) | 15.90 | 42.11 | 123.59 |
Bone Biologics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bone Biologics stock to make a market-neutral strategy. Peer analysis of Bone Biologics could also be used in its relative valuation, which is a method of valuing Bone Biologics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bone Biologics Corporate Executives
Elected by the shareholders, the Bone Biologics' board of directors comprises two types of representatives: Bone Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bone. The board's role is to monitor Bone Biologics' management team and ensure that shareholders' interests are well served. Bone Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bone Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shunichi Kuroda | CoFounder Board | Profile |